跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
uterine mesenchymal stem cells
首页
药物
uterine mesenchymal stem cells
uterine mesenchymal stem cells
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
UTERINE TREATMENT COMPOSITION, UTERINE ENVIRONMENT-IMPROVING AGENT, IMPLANTATION AID, EMBRYO TRANSPLANTATION LIQUID, SPERM TRANSPLANTATION LIQUID, AND IMPLANTATION RATE-IMPROVING AGENT
US 20260166086 A1
申请人: HIROSHIMA UNIV
优先权: 2022
EP
US
WO
3 件公开
USE OF HUMAN MESENCHYMAL STEM CELL SHEET IN TREATMENT OF UTERINE SCARS
US 20250114403 A1
申请人: BOE REGENERATIVE MEDICINE TECH CO LTD
优先权: 2022
CN
US
2 件公开
COMPOSITION FOR USE IN THE TREATMENT OF ORAL DISEASES OR CONDITIONS
EP 4570259 A1
申请人: GISTEM RES S L
优先权: 2023
EP
WO
2 件公开
Polypeptide and DNA thereof
US 7371818 B2
申请人: SHIONOGI & CO
优先权: 2000
US
2 件公开
p19Arf, HMGA2 and MDM2 For Use in the Diagnosis and Treatment of Aberrant Cell Growth
US 2013149314 A1
申请人: BULLERDIEK JOERN
优先权: 2010
US
2 件公开
Adipose tissue mesenchymal stem cells and methods of use to treat or inhibit uterine disorders
US 9498498 B2
申请人: AVITA INT LTD
优先权: 2014
US
2 件公开
Application of mesenchymal stem cells in medicine for treating thin endometrium and uterine cavity adhesion
CN 120923623 A
申请人: RUIYIN CELL ENGINEERING TECH GUANGZHOU CO LTD
优先权: 2025
CN
2 件公开
WNT4 AND MED12 FOR USE IN THE DIAGNOSIS AND TREATMENT OF TUMOR DISEASES
US 2014248294 A1
申请人: UNIV BREMEN
优先权: 2011
US
Exosome hydrogel and application
CN 114712302 A
申请人: UNIV ZHEJIANG
优先权: 2022
CN
Application of M4 complete medium in culture of uterine blood mesenchymal stem cells
CN 116121183 A
申请人: IPM BIOPHARM CO LTD
优先权: 2022
CN
第 1 / 2 页
上一页
下一页
药物
反馈